249 related articles for article (PubMed ID: 37958583)
1. Exploring the Potential of Nanoporous Materials for Advancing Ophthalmic Treatments.
Wu KY; Brister D; Bélanger P; Tran SD
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958583
[TBL] [Abstract][Full Text] [Related]
2. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
[TBL] [Abstract][Full Text] [Related]
3. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics.
Chaudhari P; Ghate VM; Lewis SA
Eur J Pharm Biopharm; 2021 Apr; 161():80-99. PubMed ID: 33607239
[TBL] [Abstract][Full Text] [Related]
4. Improvements in Topical Ocular Drug Delivery Systems: Hydrogels and Contact Lenses.
Ribeiro AM; Figueiras A; Veiga F
J Pharm Pharm Sci; 2015; 18(5):683-95. PubMed ID: 26670365
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
6. The design of contact lens based ocular drug delivery systems for single-day use: Part (I) Structural factors, surrogate ophthalmic dyes and passive diffusion studies.
Mahomed A; Tighe BJ
J Biomater Appl; 2014 Sep; 29(3):341-53. PubMed ID: 24663443
[TBL] [Abstract][Full Text] [Related]
7. Contact lenses: promising devices for ocular drug delivery.
Guzman-Aranguez A; Colligris B; Pintor J
J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
[TBL] [Abstract][Full Text] [Related]
8. Hydrogels in ophthalmic applications.
Kirchhof S; Goepferich AM; Brandl FP
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
[TBL] [Abstract][Full Text] [Related]
9. A review on therapeutic contact lenses for ocular drug delivery.
Maulvi FA; Soni TG; Shah DO
Drug Deliv; 2016 Oct; 23(8):3017-3026. PubMed ID: 26821766
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases.
Zhao L; Song J; Du Y; Ren C; Guo B; Bi H
Drug Deliv; 2023 Dec; 30(1):2219419. PubMed ID: 37264930
[TBL] [Abstract][Full Text] [Related]
11. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
Tashakori-Sabzevar F; Mohajeri SA
Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
[TBL] [Abstract][Full Text] [Related]
12. Nanosuspensions in ophthalmology: Overcoming challenges and enhancing drug delivery for eye diseases.
Fathi-Karkan S; Amiri Ramsheh N; Arkaban H; Narooie-Noori F; Sargazi S; Mirinejad S; Roostaee M; Sargazi S; Barani M; Malahat Shadman S; Althomali RH; Rahman MM
Int J Pharm; 2024 Jun; 658():124226. PubMed ID: 38744414
[TBL] [Abstract][Full Text] [Related]
13. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
14. Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems.
Wu KY; Khan S; Liao Z; Marchand M; Tran SD
Polymers (Basel); 2024 Jun; 16(12):. PubMed ID: 38932068
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on contact lens for ophthalmic drug delivery.
Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X
J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic Sensors and Drug Delivery.
Dennyson Savariraj A; Salih A; Alam F; Elsherif M; AlQattan B; Khan AA; Yetisen AK; Butt H
ACS Sens; 2021 Jun; 6(6):2046-2076. PubMed ID: 34043907
[TBL] [Abstract][Full Text] [Related]
17. Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update.
Baghban R; Talebnejad MR; Meshksar A; Heydari M; Khalili MR
J Nanobiotechnology; 2023 Nov; 21(1):402. PubMed ID: 37919748
[TBL] [Abstract][Full Text] [Related]
18. Ocular Drug Delivery Systems Using Contact Lenses.
Novack GD; Barnett M
J Ocul Pharmacol Ther; 2020 Oct; 36(8):595-601. PubMed ID: 32456518
[TBL] [Abstract][Full Text] [Related]
19. Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses.
Pelusi L; Mandatori D; Mastropasqua L; Agnifili L; Allegretti M; Nubile M; Pandolfi A
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839947
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic contact lenses for ophthalmic drug delivery: major challenges.
Zhang X; Cao X; Qi P
J Biomater Sci Polym Ed; 2020 Mar; 31(4):549-560. PubMed ID: 31902299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
